References
-
1
Modlin I, Oberg K, Chung D. et al .
Gastroenteropancreatic neuroendocrine tumours.
Lancet Oncol.
2008;
9
61-72
-
2 Modlin I, Drozdov I, Gustafsson B. et al .Rectal neuroendocrine tumors – diagnosis and treatment. In: Modlin I, Oberg K (eds). A century of advances in neuroendocrine tumor biology and treatment. Hannover; Felsenstein CCCP 2007: 124-133
-
3
Kaminski M, Polkowski M, Regula J. et al .
Prevalence and endoscopic features of rectal neuroendocrine tumors (carcinoids) among 50 148 participants of the Polish colorectal-cancer screening programme.
Gut.
2007;
56 (Suppl III)
A310
-
4
Matsui K, Iwase T, Kitagawa M.
Small, polypoid-appearing carcinoid tumors of the rectum: clinicopathologic study of 16 cases and effectiveness of endoscopic treatment.
Am J Gastroenterol.
1993;
88
1949-1953
-
5
Scherübl H.
Options for gastroenteropancreatic neuroendocrine tumours.
Lancet Oncol.
2008;
9
203
-
6
Soga J.
Early-stage carcinoids of the gastrointestinal tract: an analysis of 1914 reported cases.
Cancer.
2005;
103
1587-1595
-
7
Konishi T, Watanabe T, Kishimoto J. et al .
Prognosis and risk factors of metastasis in colorectal carcinoids: results of a nationwide registry over 15 years.
Gut..
2007;
56
863-868
-
8
Konishi T, Watanabe T, Muto T. et al .
Risk factors for lymph node and distant metastasis in colorectal carcinoids: an analysis of nationwide registry in Japan over 15 years.
J Clin Oncol.
2006;
24
ASCO Abstract 3620
-
9
Konishi T, Watanabe T, Kishimoto J. et al .
Prognosis and metastatic potential of colorectal carcinoids compared with adenocarcinomas: results of a nationwide registry over 15 years.
J Clin Oncol.
2008;
26
ASCO Abstract 4054
-
10
Sauven P, Ridge J, Quan S. et al .
Anorectal carcinoid tumors. Is aggressive surgery warranted?.
Ann Surg.
1990;
211
67-71
-
11
Tsukamoto S, Fujita S, Yamaguchi T. et al .
Clinicopathological characteristics and prognosis of rectal well-differentiated neuroendocrine tumors.
Int J Colorectal Dis.
2008;
23
1109-1113
-
12
Modlin I, Lye K, Kidd M.
A 5-decade analysis of 13 715 carcinoid tumors.
Cancer.
2003;
97
934-959
-
13
Shim K, Yang S, Myung S. et al .
Atypical endoscopic features of rectal carcinoids.
Endoscopy.
2004;
36
313-316
-
14
Wang A, Ahmad N.
Rectal carcinoids.
Curr Opin Gastroenterol.
2006;
22
529-535
-
15
Kim B N, Sohn D K, Hong C W. et al .
Atypical endoscopic features can be associated with metastasis in rectal carcinoid tumors.
Surg Endosc.
2008;
22
1992-1996
-
16
Kwaan M, Goldberg J, Bleday R. et al .
Rectal carcinoid tumors: review of results after endoscopic and surgical therapy.
Arch Surg.
2008;
143
471-475
-
17
Ramage J, Goretzki P, Manfredi R. et al .
Consensus guidelines for the management of patients with digestive neuroendocrine tumours: well-differentiated colon and rectum tumour/carcinoma.
Neuroendocrinology.
2008;
87
31-39
-
18
Shinohara T, Hotta T, Oyama T.
Rectal carcinoid tumor, 6 mm in diameter, with lymph node metastases.
Endoscopy.
2008;
40 (Suppl 2)
E40-E41
-
19
Scherübl H, Bader M, Fett U. et al .
Somatostatin-receptor imaging of neuroendocrine gastroenteropancreatic tumors.
Gastroenterology.
1993;
105
1705-1709
-
20
Sakata H, Iwakiri R, Ootani A. et al .
A pilot randomised controlled study to evaluate endoscopic resection using a ligation device for rectal carcinoid tumors.
World J Gastroenterol.
2006;
12
4026-4028
-
21
Mashimo Y, Matsuda T, Uraoka T. et al .
Endoscopic submucosal resection with a ligation device is an effective and safe treatment for carcinoid tumors in the lower rectum.
J Gastroenterol Hepatol.
2008;
23
218-221
-
22
Onozato Y, Kakizaki S, Ishihara H. et al .
Endoscopic submucosal dissection for rectal tumors.
Endoscopy.
2007;
39
423-427
-
23
Kim Y J, Lee S K, Cheon J H. et al .
Efficacy of endoscopic resection for small rectal carcinoid: a retrospective study.
Korean J Gastroenterol.
2008;
51
174-180
-
24
Kobayashi K, Katsumata T, Yoshizawa S. et al .
Indications of endoscopic polypectomy for rectal carcinoid tumors and clinical usefulness of endoscopic ultrasonography.
Dis Colon Rectum.
2005;
48
285-291
-
25
Scherübl H.
Comment on Ramage et al.: Consensus guidelines for the management of patients with digestive neuroendocrine tumours: well-differentiated colon and rectum tumour/carcinoma.
Neuroendocrinology.
2008;
88
157-159
-
26
Höpfner M, Schuppan D, Scherübl H.
Treatment of gastrointestinal neuroendocrine tumors with inhibitors of growth factor receptors and their signaling pathways: recent advances and future perspectives.
World J Gastroenterol.
2008;
14
2461-2473
H. ScherüblMD, PhD
Klinik für Innere Medizin
Gastroenterologie und Gastrointestinale Onkologie
Vivantes-Klinikum am Urban
Dieffenbachstraße 1
10967 Berlin
Germany
Fax: +49-30-130225205
eMail: hans.scheruebl@vivantes.de